CANAAN INC (CAN) Fundamental Analysis & Valuation

NASDAQ:CAN • US1347481020

Current stock price

0.4368 USD
-0.01 (-2.28%)
Last:

This CAN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CAN Profitability Analysis

1.1 Basic Checks

  • In the past year CAN has reported negative net income.
  • The reported net income has been mixed in the past 5 years: CAN reported negative net income in multiple years.
  • In the past 5 years CAN reported 4 times negative operating cash flow.
CAN Yearly Net Income VS EBIT VS OCF VS FCFCAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • The Return On Assets of CAN (-34.81%) is worse than 75.68% of its industry peers.
  • Looking at the Return On Equity, with a value of -47.98%, CAN is in line with its industry, outperforming 43.24% of the companies in the same industry.
Industry RankSector Rank
ROA -34.81%
ROE -47.98%
ROIC N/A
ROA(3y)-57.59%
ROA(5y)-25.45%
ROE(3y)-86.94%
ROE(5y)-38.39%
ROIC(3y)N/A
ROIC(5y)N/A
CAN Yearly ROA, ROE, ROICCAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

1.3 Margins

  • CAN has a Gross Margin of 7.83%. This is in the lower half of the industry: CAN underperforms 78.38% of its industry peers.
  • In the last couple of years the Gross Margin of CAN has declined.
  • The Profit Margin and Operating Margin are not available for CAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-39.65%
GM growth 5Y-1.72%
CAN Yearly Profit, Operating, Gross MarginsCAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CAN Health Analysis

2.1 Basic Checks

  • CAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The debt/assets ratio for CAN is higher compared to a year ago.
CAN Yearly Shares OutstandingCAN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CAN Yearly Total Debt VS Total AssetsCAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • CAN has an Altman-Z score of 0.51. This is a bad value and indicates that CAN is not financially healthy and even has some risk of bankruptcy.
  • CAN has a Altman-Z score of 0.51. This is in the lower half of the industry: CAN underperforms 64.86% of its industry peers.
  • CAN has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.12, CAN is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACCN/A
WACC8.65%
CAN Yearly LT Debt VS Equity VS FCFCAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 3.31 indicates that CAN has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.31, CAN belongs to the top of the industry, outperforming 86.49% of the companies in the same industry.
  • CAN has a Quick Ratio of 1.93. This is a normal value and indicates that CAN is financially healthy and should not expect problems in meeting its short term obligations.
  • CAN has a Quick ratio of 1.93. This is in the better half of the industry: CAN outperforms 75.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 1.93
CAN Yearly Current Assets VS Current LiabilitesCAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CAN Growth Analysis

3.1 Past

  • CAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.63%.
  • Looking at the last year, CAN shows a very strong growth in Revenue. The Revenue has grown by 96.28%.
  • CAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.18% yearly.
EPS 1Y (TTM)-5.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-509.09%
Revenue 1Y (TTM)96.28%
Revenue growth 3Y-6.63%
Revenue growth 5Y52.18%
Sales Q2Q%121.11%

3.2 Future

  • CAN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.61% yearly.
  • Based on estimates for the next years, CAN will show a quite strong growth in Revenue. The Revenue will grow by 19.01% on average per year.
EPS Next Y83.44%
EPS Next 2Y32.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.44%
Revenue Next 2Y19.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CAN Yearly Revenue VS EstimatesCAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CAN Yearly EPS VS EstimatesCAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. CAN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CAN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CAN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CAN Price Earnings VS Forward Price EarningsCAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAN Per share dataCAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CAN's earnings are expected to grow with 32.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.61%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CAN Dividend Analysis

5.1 Amount

  • CAN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAN Fundamentals: All Metrics, Ratios and Statistics

CANAAN INC

NASDAQ:CAN (3/20/2026, 3:54:58 PM)

0.4368

-0.01 (-2.28%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)02-10
Earnings (Next)05-18
Inst Owners23.76%
Inst Owner Change75.19%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap296.30M
Revenue(TTM)529.96M
Net Income(TTM)-209.84M
Analysts81.82
Price Target2.16 (394.51%)
Short Float %135.75%
Short Ratio3.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-285.15%
Min EPS beat(2)-563.37%
Max EPS beat(2)-6.93%
EPS beat(4)1
Avg EPS beat(4)-217.67%
Min EPS beat(4)-563.37%
Max EPS beat(4)10.88%
EPS beat(8)4
Avg EPS beat(8)-140.38%
EPS beat(12)4
Avg EPS beat(12)-129.98%
EPS beat(16)6
Avg EPS beat(16)-93.94%
Revenue beat(2)2
Avg Revenue beat(2)11.68%
Min Revenue beat(2)10.68%
Max Revenue beat(2)12.67%
Revenue beat(4)2
Avg Revenue beat(4)1.53%
Min Revenue beat(4)-9.04%
Max Revenue beat(4)12.67%
Revenue beat(8)6
Avg Revenue beat(8)7.57%
Revenue beat(12)8
Avg Revenue beat(12)6.53%
Revenue beat(16)10
Avg Revenue beat(16)37.5%
PT rev (1m)-26.64%
PT rev (3m)-26.64%
EPS NQ rev (1m)-14.29%
EPS NQ rev (3m)50%
EPS NY rev (1m)67.74%
EPS NY rev (3m)-129.41%
Revenue NQ rev (1m)-60.34%
Revenue NQ rev (3m)-62.47%
Revenue NY rev (1m)-38.56%
Revenue NY rev (3m)-41.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.56
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.84
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.78
BVpS0.64
TBVpS0.52
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.81%
ROE -47.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.83%
FCFM N/A
ROA(3y)-57.59%
ROA(5y)-25.45%
ROE(3y)-86.94%
ROE(5y)-38.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-39.65%
GM growth 5Y-1.72%
F-ScoreN/A
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.31
Quick Ratio 1.93
Altman-Z 0.51
F-ScoreN/A
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-509.09%
EPS Next Y83.44%
EPS Next 2Y32.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)96.28%
Revenue growth 3Y-6.63%
Revenue growth 5Y52.18%
Sales Q2Q%121.11%
Revenue Next Year-13.44%
Revenue Next 2Y19.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CANAAN INC / CAN Fundamental Analysis FAQ

What is the fundamental rating for CAN stock?

ChartMill assigns a fundamental rating of 3 / 10 to CAN.


What is the valuation status of CANAAN INC (CAN) stock?

ChartMill assigns a valuation rating of 1 / 10 to CANAAN INC (CAN). This can be considered as Overvalued.


Can you provide the profitability details for CANAAN INC?

CANAAN INC (CAN) has a profitability rating of 1 / 10.


What is the financial health of CANAAN INC (CAN) stock?

The financial health rating of CANAAN INC (CAN) is 3 / 10.


Can you provide the expected EPS growth for CAN stock?

The Earnings per Share (EPS) of CANAAN INC (CAN) is expected to grow by 83.44% in the next year.